Davis B - Search Results

1

Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.

Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B. Corsino P, et al. Among authors: davis b. Cancer Res. 2007 Apr 1;67(7):3135-44. doi: 10.1158/0008-5472.CAN-06-3815. Cancer Res. 2007. PMID: 17409420

2

Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.

Corsino PE, Davis BJ, Nørgaard PH, Parker NN, Law M, Dunn W, Law BK. Corsino PE, et al. Neoplasia. 2008 Nov;10(11):1240-52. doi: 10.1593/neo.08710. Neoplasia. 2008. PMID: 18953433 Free PMC article.

3

An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch.

Jahn SC, Law ME, Corsino PE, Parker NN, Pham K, Davis BJ, Lu J, Law BK. Jahn SC, et al. Cancer Lett. 2012 Dec 30;326(2):183-90. doi: 10.1016/j.canlet.2012.08.013. Epub 2012 Aug 17. Cancer Lett. 2012. PMID: 22906417 Free PMC article.

4

Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints.

Jahn SC, Corsino PE, Davis BJ, Law ME, Nørgaard P, Law BK. Jahn SC, et al. J Cell Sci. 2013 Mar 1;126(Pt 5):1207-17. doi: 10.1242/jcs.117382. Epub 2013 Jan 15. J Cell Sci. 2013. PMID: 23321641 Free PMC article.

5

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

Jahn SC, Law ME, Corsino PE, Rowe TC, Davis BJ, Law BK. Jahn SC, et al. Biochemistry. 2013 May 21;52(20):3489-501. doi: 10.1021/bi400047u. Epub 2013 May 9. Biochemistry. 2013. PMID: 23627734 Free PMC article.

6

Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.

Law M, Forrester E, Chytil A, Corsino P, Green G, Davis B, Rowe T, Law B. Law M, et al. Among authors: davis b. Cancer Res. 2006 Jan 15;66(2):1070-80. doi: 10.1158/0008-5472.CAN-05-1672. Cancer Res. 2006. PMID: 16424043

7

Signaling mechanisms that suppress the cytostatic actions of rapamycin.

Jahn SC, Law ME, Corsino PE, Davis BJ, Harrison JK, Law BK. Jahn SC, et al. PLoS One. 2014 Jun 13;9(6):e99927. doi: 10.1371/journal.pone.0099927. eCollection 2014. PLoS One. 2014. PMID: 24927123 Free PMC article.

8

CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.

Law ME, Ferreira RB, Davis BJ, Higgins PJ, Kim JS, Castellano RK, Chen S, Luesch H, Law BK. Law ME, et al. Among authors: davis bj. Breast Cancer Res. 2016 Aug 5;18(1):80. doi: 10.1186/s13058-016-0741-1. Breast Cancer Res. 2016. PMID: 27495374 Free PMC article.

9

Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.

Law ME, Yaaghubi E, Ghilardi AF, Davis BJ, Ferreira RB, Koh J, Chen S, DePeter SF, Schilson CM, Chiang CW, Heldermon CD, Nørgaard P, Castellano RK, Law BK. Law ME, et al. Among authors: davis bj. Cancer Lett. 2022 May 28;534:215604. doi: 10.1016/j.canlet.2022.215604. Epub 2022 Mar 2. Cancer Lett. 2022. PMID: 35247515

10

Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Law ME, Corsino PE, Jahn SC, Davis BJ, Chen S, Patel B, Pham K, Lu J, Sheppard B, Nørgaard P, Hong J, Higgins P, Kim JS, Luesch H, Law BK. Law ME, et al. Among authors: davis bj. Oncogene. 2013 Mar 7;32(10):1316-29. doi: 10.1038/onc.2012.138. Epub 2012 Apr 30. Oncogene. 2013. PMID: 22543582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,968 results

Search Page

Filters